Differences in substance use disorders and other mental disorders in mental health and addiction settings: Sociodemographic, clinical, drug treatment, and gender differences
Saved in:
Fernández, J.J., et al., Differences in substance use disorders and other mental disorders in mental health and addiction settings: Sociodemographic, clinical, drug treatment, and gender differences. International Journal of Mental Health and Addiction, online (december), 2022, 19 p.
Ref.
581815
Location:
SIIS Archivo
Palabras clave:
Drogodependencias, Drogas ilegales, Consumo, Hombre, Mujer, Diagnóstico dual, Enfermedades mentales, Centros de salud mental, Tratamiento médico, Recetas médicas, Evaluación, Evaluación de servicios, Características usuario, Datos estadísticos, España
Drogodependencias, Drogas ilegales, Consumo, Hombre, Mujer, Diagnóstico dual, Enfermedades mentales, Centros de salud mental, Tratamiento médico, Recetas médicas, Evaluación, Evaluación de servicios, Características usuario, Datos estadísticos, España
Abstract:
Este estudio propone diseñar la primera escala para evaluar el Síndrome Amotivacional en consumidores de cannabis.
Este estudio propone diseñar la primera escala para evaluar el Síndrome Amotivacional en consumidores de cannabis.
Similar Items: Differences in substance use disorders and other mental disorders in mental health and addiction settings: Sociodemographic, clinical, drug treatment, and gender differences
- ASSESSMENT OF CO-OCCURRING ADDICTIVE AND OTHER MENTAL DISORDERS. EN: EVIDENCE-BASED ADDICTION TREATMENT
- SEX DIFFERENCES IN SMOKING CESSATION OUTCOMES OF A TAILORED PROGRAM FOR INDIVIDUALS WITH SUBSTANCE USE DISORDERS AND MENTAL ILLNESS
- Implications of epidemiological data for identifying persons with substance use and other mental Disorders
- SCREENING FOR AND ASSESSMENT OF CO-OCCURRING SUBSTANCE USE AND MENTAL HEALTH DISORDERS BY ALCOHOL AND OTHER DRUG AND MENTAL HEALTH SERVICES
- Gender Differences in Substance Use, Consequences, Motivation to Change, and Treatment Seeking in People With Serious Mental Illness
- SCREENING FOR CO-OCCURRING MENTAL DISORDERS IN DRUG TREATMENT POPULATIONS